J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection
Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Read Article
Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Read Article
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu